Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.
This article was originally published on MedicalXpress.com
Stud reveals more type 1 diabetics are obese, taking GLP-1 drugs
You may also be interested in:
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
Exploring Attachment Styles and How They Affect Adult Relationships
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
Read More:
-
There is a nationwide shortage of pediatric specialists, delaying care for many patients. In some cases, children wait weeks or even months for appointments. But [...]
-
Economic disadvantage leaves a biological imprint on children which could last throughout their lifetime, reducing their quality and length of life. These are the findings [...]
-
New research from the Monell Chemical Senses Center and Temple University about nutritional biomarkers using carbon and nitrogen stable isotope ratios showed very different results [...]
